The Business of Biotech: What You Need to Know Going Into 2025
As we approach the start of a new year, we're thinking about what trends will be impacting the biotech industry in 2025. And how can biotech executives, communications and marketing officers can get ahead in this landscape. We held a panel discussion recently with STAT to review the current state of the biotech industry and explore strategies to prepare for the challenges and opportunities in 2025.
Tune in to hear expert perspectives on what to look for in the biotech sector from a policy, financial and AI perspective and learn about key trends we're watching to ensure organizations succeed next year and beyond.
Featured speakers:
-
Detlev Biniszkiewicz, Ph.D., Investment Partner, MPM Capital
-
Erin Crocker, Practice Leader Client Services, Real Chemistry
-
Mary Claire Duch, Group President, Integrated Communications, Real Chemistry
-
Paul Edattel, Principal, Todd Strategy Group, LLC
-
Eric Olson, Chief Business Officer, Stoke Therapeutics
Looking for insights, stories and ideas that are changing healthcare? Subscribe to our Healthcare Connection newsletter and get transformative ideas delivered to your inbox every month.
